- Home
- CAPT vs LUMO Comparison
CAPT vs LUMO Comparison
Compare CAPT & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- LUMO
- Stock Information
- Founded
- CAPT 2005
- LUMO 2011
- Country
- CAPT South Korea
- LUMO United States
- Employees
- CAPT N/A
- LUMO N/A
- Industry
- CAPT Blank Checks
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- LUMO Health Care
- Exchange
- CAPT Nasdaq
- LUMO Nasdaq
- Market Cap
- CAPT 41.9M
- LUMO 37.7M
- IPO Year
- CAPT N/A
- LUMO N/A
- Fundamental
- Price
- CAPT $0.88
- LUMO $4.33
- Analyst Decision
- CAPT
- LUMO Buy
- Analyst Count
- CAPT 0
- LUMO 4
- Target Price
- CAPT N/A
- LUMO $9.38
- AVG Volume (30 Days)
- CAPT 145.7K
- LUMO 130.8K
- Earning Date
- CAPT 01-01-0001
- LUMO 11-07-2024
- Dividend Yield
- CAPT N/A
- LUMO N/A
- EPS Growth
- CAPT N/A
- LUMO N/A
- EPS
- CAPT N/A
- LUMO N/A
- Revenue
- CAPT $17,389,944.00
- LUMO $2,205,000.00
- Revenue This Year
- CAPT N/A
- LUMO $184.11
- Revenue Next Year
- CAPT N/A
- LUMO N/A
- P/E Ratio
- CAPT N/A
- LUMO N/A
- Revenue Growth
- CAPT 84.70
- LUMO 300.59
- 52 Week Low
- CAPT $0.76
- LUMO $1.37
- 52 Week High
- CAPT $7.92
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- CAPT 21.22
- LUMO 56.58
- Support Level
- CAPT $0.76
- LUMO $4.25
- Resistance Level
- CAPT $1.42
- LUMO $4.44
- Average True Range (ATR)
- CAPT 0.14
- LUMO 0.11
- MACD
- CAPT -0.04
- LUMO -0.03
- Stochastic Oscillator
- CAPT 14.19
- LUMO 33.33
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.